Colomycin Injection
Last Updated on eMC 05-Feb-2016 View document | Teva UK Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05-Feb-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 5 - how to store
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
- Change to information for healthcare professionals
- Change to section 3 - dose and frequency
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - what you need to know - warnings and precautions
Updated on 14-Sep-2015 and displayed until 05-Feb-2016
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 31-Oct-2012 and displayed until 14-Sep-2015
Reasons for adding or updating:
- Change due to harmonisation of PIL.
- Change to date of revision
Updated on 04-May-2010 and displayed until 31-Oct-2012
Reasons for adding or updating:
- Addition of information on alternative format leaflets
- Change to Further Information section
- Change to date of revision
- Change of manufacturer
- Change to dosage and administration
- Change due to user-testing of patient information
- Change to MA holder contact details
Updated on 08-Sep-2005 and displayed until 04-May-2010
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 17-Aug-2005 and displayed until 08-Sep-2005
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 17-Mar-2005 and displayed until 17-Aug-2005
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 12-Jan-2005 and displayed until 17-Mar-2005
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Teva UK Limited
Field House, Station Approach, Harlow, Essex, CM20 2FB
+44 (0)207 540 7169
+44 (0)207 540 7000
+44 (0)207 540 7117
+44 (0)207 540 7349
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue